Heme Arginate in Functional Magnetic Resonance Imaging (fMRI)
NCT01461512
·
clinicaltrials.gov ↗
PHASE2
Phase
UNKNOWN
Status
16
Enrollment
OTHER
Sponsor class
Conditions
Ischemia-reperfusion Injury
Interventions
DRUG:
heme arginate administration
DRUG:
Placebo administration
Sponsor
MWolzt